Web Content Management
PRODUCTS
-
The 132M HC sets the standard for performance, precision, and reliability. This wrap-around labeler applies labels to cylindrical products with the utmost accuracy at the highest performance.
-
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
-
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
Designed as a dedicated, short-range logistics service for the life sciences, Cryoshuttle reinforces chain of custody, ensures near real-time visibility, and preserves product integrity from start to finish.
-
Discover the expanded DSM series, featuring a 60V/18A option, which provides engineers with greater design flexibility. The DSM series is designed for fast, safe integration into new or existing systems.
WHITE PAPERS AND CASE STUDIES
-
Pasteurized Equivalent Water For AgriMark-Cabot Dairy In Vermont
Discover how AgriMark-Cabot Dairy transformed wastewater into a valuable resource using UV technology, achieving significant energy and water savings while maintaining stringent food safety standards.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Tackling Antimicrobial Resistance
Learn how three companies collaborated to develop a new antibiotic to address the increasing development of antimicrobial resistance (AMR) that threatens the global health landscape.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Mobile App And Wearable Integration Collects Longitudinal Data
Get an overview of SISCAPA's utilization of eTechnologies, specifically ePRO, and how their partnership with CDS accurately demonstrates the improvement of data collection and analysis in the biotechnology industry.
-
Sustainable Solutions For Medical Devices
Explore how medical device companies aim to balance patient safety with environmental stability by offering bio-based UHMWPE, which reduces carbon footprints by up to 70%.
-
How A Leading CDMO Reduced Yield Variability With Automation
Explore the transformative journey of a leading CDMO company and how they adopted an innovative platform that enhances data analytics and drives pharmaceutical manufacturing advancements.
-
Driving Customer Profitability With Enterprise Platform, Pricing
Explore how the solutions and approaches offered by CDS can help different research stakeholders conduct more cost-efficient clinical trials in the industry's pharmaceutical, biotech, and device sectors.
-
Simplify CAPA In 7 Steps
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Digital Transformation - The Power Of Your Data
Discover how you can circumvent numerous recirculations during the ultrafiltration process step, boost downstream bioprocess yield, and identify and resolve process inefficiencies.
NEWS
-
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems5/13/2025
Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in blood volume measurement technology, announces the expansion of its innovative diagnostic solutions into two additional U.S. healthcare systems, further advancing the standard of care for cardiovascular and critical care patients nationwide.
-
Athelas Strengthens Market Leadership In Strategic Partnership With Resilient Healthcare3/7/2025
Athelas, powered by Commure, announced a strategic partnership with Resilient Healthcare Corp, a trailblazer in health-at-home solutions, to launch a groundbreaking pilot program aimed at revolutionizing outpatient care and hospital billing.
-
Decimal Point Analytics Launches DocuAgentIQ - Agentic AI Platform Transforming Document Workflows In SBA & CRE Lending8/23/2025
Decimal Point Analytics today announced DocuAgentIQ, a purpose-built Agentic AI platform that modernizes document-heavy work across SBA and CRE lending.
-
Alvotech Appoints Dr. Balaji V. Prasad As Chief Strategy Officer3/27/2025
Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad as Chief Strategy Officer.
-
Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (fCAL®) Turbo And Fecal Pancreatic Elastase (fPELA®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa)7/14/2025
QuidelOrtho Corporation ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA.